To define the frequency of ANCA autoimmunity in patients with SARS-CoV-2 infection we studied the serum ANCAs and the serum PR3 and MPO antigens in asymptomatic and in hospitalized COVID-19 patients at hospital admission and one week after the recovery. This evidence concerns the gene MPO and COVID-19.